| (210) | Number of the EPO application | 17710748 |
| (220) | Filing date of the EPO application | 2017.03.16 |
| (80) | EPO patent specification publication (B) | EPB nr. 35/2023, 2023.08.30 |
| (110) | EPO patent number | 3430043 |
| (11) | Number of the document | MD 3430043 T2 |
| (21) | Number of the application | e 2019 0099 |
| (71) | Name(s) of applicant(s), code of the country | TILLOTTS PHARMA AG, CH; |
| (72) | Name(s) of inventor(s), code of the country | GUNDE Tea, CH;
MEYER Sebastian, CH;
FURRER Esther Maria, CH; |
| (73) | Name(s) of owner(s), code of the country | TILLOTTS PHARMA AG, CH; |
| (54) | Title of the invention | Anti-TNF alpha-antibodies and functional fragments thereof |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | C07K 16/24 (2006.01.01); A61P 1/00 (2006.01.01) |
| (19) | Country | CH |
| (41) | Date of publication of the application | 2019.02.28 |
| (49) | Date of publication of the translation of the validated European patent specification | 2024.02.29 |
| (30) | Priority | 16160907, 2016.03.17, EP |
| (74) | Patent attorney | (Procedură) CORCODEL Angela, Bd. Ştefan cel Mare nr. 134, Chişinău, Republica Moldova |
| (86) | International application | PCT/EP2017/056237, 2017.03.16 |
| (87) | International publication | WO 2017/158092, 2017.09.21 |